Published in J Virol on April 04, 2012
A cholesterol recognition amino acid consensus domain in GP64 fusion protein facilitates anchoring of baculovirus to mammalian cells. J Virol (2013) 0.88
Interplay between the Herpes Simplex Virus 1 gB Cytodomain and the gH Cytotail during Cell-Cell Fusion. J Virol (2015) 0.84
Functional fluorescent protein insertions in herpes simplex virus gB report on gB conformation before and after execution of membrane fusion. PLoS Pathog (2014) 0.80
The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella Zoster Virus Cell-Cell Fusion Regulation and Infection. J Virol (2016) 0.76
The fusion loops and membrane proximal region of Epstein-Barr virus glycoprotein B (gB) can function in the context of herpes simplex virus 1 gB when substituted individually but not in combination. Virus Res (2012) 0.76
Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage. Sci Rep (2017) 0.75
Conservation of the glycoprotein B homologs of the Kaposi׳s sarcoma-associated herpesvirus (KSHV/HHV8) and old world primate rhadinoviruses of chimpanzees and macaques. Virology (2016) 0.75
Structure-Based Mutations in the Herpes Simplex Virus 1 Glycoprotein B Ectodomain Arm Impart a Slow-Entry Phenotype. MBio (2017) 0.75
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell (1996) 9.03
Viral membrane fusion. Nat Struct Mol Biol (2008) 8.54
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Crystal structure of glycoprotein B from herpes simplex virus 1. Science (2006) 5.57
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol (1991) 5.14
Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell (1999) 4.17
Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science (2006) 4.11
Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology (2001) 3.82
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76
Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol (1987) 3.51
Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci U S A (2005) 3.25
Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol (2003) 3.14
Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science (2007) 2.97
Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol (2011) 2.86
Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol (1994) 2.83
Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol (2007) 2.82
Entry of herpesviruses into mammalian cells. Cell Mol Life Sci (2008) 2.79
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology (1999) 2.21
Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol (2005) 2.19
The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol (2008) 2.09
Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc Natl Acad Sci U S A (2009) 2.05
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol (1988) 1.94
Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor. Virology (2000) 1.91
Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J Virol (2003) 1.78
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol (2005) 1.76
Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J Virol (2009) 1.65
Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J Virol (2007) 1.56
Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci U S A (2004) 1.41
Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion. J Virol (1993) 1.40
Leash in the groove mechanism of membrane fusion. Nat Struct Biol (2003) 1.36
Random linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein B. Proc Natl Acad Sci U S A (2007) 1.35
Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J Virol (2000) 1.33
Truncation of herpes simplex virus type 2 glycoprotein B increases its cell surface expression and activity in cell-cell fusion, but these properties are unrelated. J Virol (2002) 1.29
Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J Virol (2007) 1.28
X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A (2011) 1.27
Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology (1989) 1.22
Alanine substitution of conserved residues in the cytoplasmic tail of herpes simplex virus gB can enhance or abolish cell fusion activity and viral entry. Virology (2005) 1.17
Low pH-induced conformational change in herpes simplex virus glycoprotein B. J Virol (2010) 1.16
Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1. J Virol (2010) 1.14
Capturing the herpes simplex virus core fusion complex (gB-gH/gL) in an acidic environment. J Virol (2011) 1.07
Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus. J Biol Chem (2011) 1.06
Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity. J Gen Virol (2007) 1.06
The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules. Chembiochem (2008) 1.02
Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection. Antimicrob Agents Chemother (2008) 1.00
Syncytial phenotype of C-terminally truncated herpes simplex virus type 1 gB is associated with diminished membrane interactions. J Virol (2010) 0.98
An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J Virol (2003) 0.96
Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity. J Virol (2011) 0.95
Fusion-deficient insertion mutants of herpes simplex virus type 1 glycoprotein B adopt the trimeric postfusion conformation. J Virol (2009) 0.91
Use of a neural network secondary structure prediction to define targets for mutagenesis of herpes simplex virus glycoprotein B. Virus Res (1998) 0.89
Identification of functional domains in herpes simplex virus 2 glycoprotein B. J Virol (2006) 0.89
Herpesvirus entry: an update. J Virol (2003) 5.19
Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol (2011) 2.86
Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc Natl Acad Sci U S A (2009) 2.05
Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell (2002) 1.99
Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptor-activated virus entry. Structure (2009) 1.91
Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc Natl Acad Sci U S A (2010) 1.75
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene (2004) 1.72
Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc Natl Acad Sci U S A (2004) 1.72
The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells. J Virol (2005) 1.70
Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion. J Virol (2004) 1.49
Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion. J Virol (2006) 1.48
Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem (2006) 1.37
Hydrophobic residues that form putative fusion loops of Epstein-Barr virus glycoprotein B are critical for fusion activity. J Virol (2007) 1.28
Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion. J Virol (2007) 1.22
Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol (2007) 1.20
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A (2003) 1.20
Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood (2003) 1.19
Mutational analysis of the HLA class II interaction with Epstein-Barr virus glycoprotein 42. J Virol (2003) 1.18
Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol (2004) 1.16
Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J Virol (2003) 1.14
Lysine-independent ubiquitination of Epstein-Barr virus LMP2A. Virology (2002) 1.13
Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins. Virology (2007) 1.13
Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol (2005) 1.13
The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells. MBio (2012) 1.12
Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion. J Virol (2009) 1.10
Ubiquitinylation of Ig beta dictates the endocytic fate of the B cell antigen receptor. J Immunol (2007) 1.09
Analysis of fusion using a virus-free cell fusion assay. Methods Mol Biol (2005) 1.08
Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays. J Virol (2010) 1.05
Cleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes. J Virol (2009) 1.03
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle (2010) 1.02
Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol (2004) 1.01
The large groove found in the gH/gL structure is an important functional domain for Epstein-Barr virus fusion. J Virol (2013) 1.01
Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology (2006) 1.01
Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog (2012) 1.00
EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J Gen Virol (2008) 0.99
Insertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry. J Virol (2009) 0.98
The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion. J Virol (2010) 0.97
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol (2006) 0.96
Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol (2005) 0.96
Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. J Virol (2011) 0.96
Reevaluating herpes simplex virus hemifusion. J Virol (2010) 0.95
Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis. J Virol (2008) 0.94
Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein-Barr virus. J Gen Virol (2003) 0.93
Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J Virol (2003) 0.91
An auto-regulatory loop for EBV LMP2A involves activation of Notch. Virology (2007) 0.90
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood (2008) 0.90
Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases. J Antimicrob Chemother (2003) 0.90
Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood (2013) 0.90
Herpesvirus entry mediator is a serotype specific determinant of pathogenesis in ocular herpes. Proc Natl Acad Sci U S A (2012) 0.89
Characteristics of Epstein-Barr virus envelope protein gp42. Virus Genes (2010) 0.89
Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion. Virology (2007) 0.89
Modulation of Epstein-Barr virus glycoprotein B (gB) fusion activity by the gB cytoplasmic tail domain. MBio (2013) 0.89
Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A. Antiviral Res (2012) 0.88
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. Proc Natl Acad Sci U S A (2009) 0.88
Investigation of the function of the putative self-association site of Epstein-Barr virus (EBV) glycoprotein 42 (gp42). Virology (2011) 0.88
Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry. J Virol (2012) 0.88
Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation. Virology (2004) 0.88
Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity. J Virol (2006) 0.87
Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn. J Virol (2008) 0.87
A soluble form of Epstein-Barr virus gH/gL inhibits EBV-induced membrane fusion and does not function in fusion. Virology (2012) 0.86
A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels. Genomics (2005) 0.86
Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma. Mol Cancer Ther (2011) 0.86
Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J Gen Virol (2009) 0.85
Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol (2007) 0.85
Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes. BMC Genomics (2005) 0.85
Epstein-Barr virus LMP2A: regulating cellular ubiquitination processes for maintenance of viral latency? Trends Immunol (2004) 0.85
The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling. Virology (2008) 0.84
The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease. Front Biosci (2002) 0.84
Epstein-Barr virus LMP2A imposes sensitivity to apoptosis. J Gen Virol (2010) 0.84
EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology (2008) 0.83
Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1. Proc Natl Acad Sci U S A (2012) 0.83
Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol (2007) 0.83
Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gL. Virology (2011) 0.82
LMP2A does not require palmitoylation to localize to buoyant complexes or for function. J Virol (2004) 0.81
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Sci Rep (2012) 0.81
A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma. Blood (2011) 0.80
Bruton's tyrosine kinase regulates B cell antigen receptor-mediated JNK1 response through Rac1 and phospholipase C-gamma2 activation. FEBS Lett (2002) 0.80
Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Antiviral Res (2002) 0.79
Is nectin-1 the "master" receptor for deadly herpes B virus infection? Virulence (2012) 0.79
Pre-B-cell colony formation assay. Methods Mol Biol (2005) 0.79
Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines. J Virol (2004) 0.78
Absence of the Epstein-Barr virus genome in breast cancer-derived cell lines. J Natl Cancer Inst (2003) 0.78
The fusion loops and membrane proximal region of Epstein-Barr virus glycoprotein B (gB) can function in the context of herpes simplex virus 1 gB when substituted individually but not in combination. Virus Res (2012) 0.76
Off-targeting oft-targeted CD20 in cHL. Blood (2012) 0.75
Drosophila Schneider 2 (S2) cells: a novel tool for studying HSV-induced membrane fusion. Virology (2013) 0.75
Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytes. J Biol Chem (2001) 0.75
Expression and characterization of N-terminal domain of Epstein-Barr virus latent membrane protein 2A in Escherichia coli. Protein Expr Purif (2005) 0.75